275 related articles for article (PubMed ID: 15962524)
1. Cetuximab.
Goldberg RM
Nat Rev Drug Discov; 2005 May; Suppl():S10-1. PubMed ID: 15962524
[TBL] [Abstract][Full Text] [Related]
2. Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer.
Lee D
Clin Colorectal Cancer; 2004 Sep; 4(3):159-62. PubMed ID: 15377399
[No Abstract] [Full Text] [Related]
3. Cetuximab: appraisal of a novel drug against colorectal cancer.
Hildebrandt B; le Coutre P; Nicolaou A; Köble K; Riess H; Dörken B
Recent Results Cancer Res; 2007; 176():135-43. PubMed ID: 17607921
[TBL] [Abstract][Full Text] [Related]
4. Cetuximab: from bench to bedside.
Vincenzi B; Zoccoli A; Pantano F; Venditti O; Galluzzo S
Curr Cancer Drug Targets; 2010 Feb; 10(1):80-95. PubMed ID: 20088790
[TBL] [Abstract][Full Text] [Related]
5. Cetuximab for treatment of metastatic colorectal cancer.
Cerea G; Ricotta R; Schiavetto I; Maugeri MR; Sartore-Bianchi A; Moroni M; Artale S; Siena S
Ann Oncol; 2006 Jun; 17 Suppl 7():vii66-7. PubMed ID: 16760297
[TBL] [Abstract][Full Text] [Related]
6. Cetuximab for metastatic colorectal cancer.
Sharma SP
Lancet Oncol; 2007 Aug; 8(8):673. PubMed ID: 17726778
[No Abstract] [Full Text] [Related]
7. Cetuximab.
Graham J; Muhsin M; Kirkpatrick P
Nat Rev Drug Discov; 2004 Jul; 3(7):549-50. PubMed ID: 15272498
[No Abstract] [Full Text] [Related]
8. Cetuximab in the treatment of metastatic colorectal cancer.
Moosmann N; Heinemann V
Expert Opin Biol Ther; 2007 Feb; 7(2):243-56. PubMed ID: 17250462
[TBL] [Abstract][Full Text] [Related]
9. Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy.
Martinelli E; De Palma R; Orditura M; De Vita F; Ciardiello F
Clin Exp Immunol; 2009 Oct; 158(1):1-9. PubMed ID: 19737224
[TBL] [Abstract][Full Text] [Related]
10. Biotech firm faces challenges from FDA, falling stock prices.
Reynolds T
J Natl Cancer Inst; 2002 Mar; 94(5):326-8. PubMed ID: 11880468
[No Abstract] [Full Text] [Related]
11. Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe.
Resch G; Schaberl-Moser R; Kier P; Kopetzky G; Scheithauer W; Sliwa T; Greil R; Nösslinger T; Mayrbäurl B; Thaler J
Ann Oncol; 2011 Feb; 22(2):486-7. PubMed ID: 21239398
[No Abstract] [Full Text] [Related]
12. Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer.
Jean GW; Shah SR
Pharmacotherapy; 2008 Jun; 28(6):742-54. PubMed ID: 18503402
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies against vascular endothelial growth factor and epidermal growth factor receptor in advanced colorectal cancers: present and future directions.
Starling N; Cunningham D
Curr Opin Oncol; 2004 Jul; 16(4):385-90. PubMed ID: 15187895
[TBL] [Abstract][Full Text] [Related]
14. Predicting response of molecular targeted therapies: a still possible challenge?
Labianca R; Garassino M; Torri V
Ann Oncol; 2008 May; 19(5):829-30. PubMed ID: 18296420
[No Abstract] [Full Text] [Related]
15. Bevacizumab.
Ellis LM
Nat Rev Drug Discov; 2005 May; Suppl():S8-9. PubMed ID: 15962523
[TBL] [Abstract][Full Text] [Related]
16. Rationale and clinical validation of epidermal growth factor receptor as a target in the treatment of head and neck cancer.
Caponigro F
Anticancer Drugs; 2004 Apr; 15(4):311-20. PubMed ID: 15057134
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody therapy of pancreatic cancer with cetuximab: potential for immune modulation.
Luedke E; Jaime-Ramirez AC; Bhave N; Carson WE
J Immunother; 2012 Jun; 35(5):367-73. PubMed ID: 22576341
[TBL] [Abstract][Full Text] [Related]
18. Cetuximab (Imclone/Merck/Bristol-Myers Squibb).
Kies MS; Harari PM
Curr Opin Investig Drugs; 2002 Jul; 3(7):1092-100. PubMed ID: 12186273
[TBL] [Abstract][Full Text] [Related]
19. Integration of novel agents in the treatment of colorectal cancer.
Iqbal S; Lenz HJ
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512
[TBL] [Abstract][Full Text] [Related]
20. Cetuximab (erbitux).
Bou-Assaly W; Mukherji S
AJNR Am J Neuroradiol; 2010 Apr; 31(4):626-7. PubMed ID: 20167650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
